Extend your learning Learn about effective ways to address problematic opioid use and overdose. DPA has an action plan that outlines a robust response focused on effective treatment, harm reduction, prevention, and… Read More
Browse Our Resources
This issue brief explains New York's new 911 Good Samaritan Law that went into effect on September 18, 2011. Enclosed is background information about overdose deaths in New York, details about the new law which seeks to… Read More
The U.S. Food and Drug Administration (FDA) has approved three medications for use in treating opioid dependence: methadone, buprenorphine, and naltrexone. Extended release naltrexone, brand name Vivitrol®, is a… Read More
Under HAT, pharmacological heroin is administered under strict controls in a clinical setting to those who have failed in other treatments like methadone. Every published evaluation of HAT has shown extremely positive… Read More
This fact sheet explains how 911 Good Samaritan laws can save lives. These laws protect people from arrest and prosecution for drug possession when they call 911 to report an overdose.
List of states with 911 Good Samaritan laws and/or naloxone access policies in place.
Statement of Support
On April 7, 2015, Ethan Nadelmann, Executive Director of the Drug Policy Alliance, presented oral testimony in support of sections 11-20 of SB275 at a hearing of the Nevada State Senate Revenue and Economic Development… Read More
The U.S. refuses to adopt an evidence-based HIV/AIDS prevention strategy, costing us hundreds of thousands of lives and hundreds of millions of dollars. However, in countries where addiction is treated as a health issue… Read More
On January 1, 2013, California became the tenth state to implement a 911 Good Samaritan overdose fatality prevention law. This law is designed to encourage people to quickly seek medical care for an overdose victim by… Read More
Editorial by the Post-Standard in favor of speading the word on 911 Good Samaritan, calling it a "life-saving new law."